Mendelian randomization shows a causal effect of low Vitamin D on multiple sclerosis risk

Neurology: Genetics

Volumn 2, Issue 5, 2016, Pages

  Rhead, Brooke ^a   Bäärnhielm, Maria ^b   Gianfrancesco, Milena ^a   Mok, Amanda ^a   Shao, Xiaorong ^a   Quach, Hong ^a   Shen, Ling ^c   Schaefer, Catherine ^c,d   Link, Jenny ^e   Gyllenberg, Alexandra ^e   Hedström, Anna Karin ^b   Olsson, Tomas ^e   Hillert, Jan ^e   Kockum, Ingrid ^e   Glymour, M Maria ^f   Alfredsson, Lars ^b,g   Barcellos, Lisa F ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DIVISION OF RESEARCH   (United States)

^d KAISER PERMANENTE   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; HLA DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; BODY MASS; CAUSAL ATTRIBUTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MULTIPLE SCLEROSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL;

EID: 85046981871     PISSN: None     EISSN: 23767839     Source Type: Journal    
DOI: 10.1212/NXG.0000000000000097     Document Type: Article

References (34)

1. Sundström P., Salzer J. Vitamin D and multiple sclerosis-from epidemiology to prevention. Acta Neurol Scand 2015; 132:56-61.
2. Smith GD, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32:1-22.
3. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82:703-710.
4. Polman CH, Reingold SC, Banwell B, et al Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69:292-302.
5. Roxburgh RHSR, Seaman SR, Masterman T, et al Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.
6. Kvale MN, Hesselson S, Hoffmann T.J., et al. Genotyping informatics and quality control for 100,000 subjects in the genetic epidemiology research on Adult health and aging (GERA) cohort. Genetics 2015; 200:1051-1060.
7. Banda Y, Kvale MN, Hoffmann T.J., et al. Characterizing race/ethnicity and genetic ancestry for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) cohort. Genetics 2015; 200:1285-1295.
8. Hedström A.K., Hillert J, Olsson T., Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014; 71:300-305.
9. Hedström A.K., Åkerstedt T, Olsson T, Alfredsson L. Shift work influences multiple sclerosis risk. Mult Scler 2015; 21:1195-1199.
10. Gianfrancesco MA, Acuna B, Shen L., et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obes Res Clin Pract 2014; 8: e435-e447.
11. Briggs FBS, Acuña BS, Shen L., et al. Adverse socioeconomic position during the life course is associated with multiple sclerosis. J Epidemiol Community Health 2014; 68: 622-629.
12. Barcellos LF, Sawcer S, Ramsay P.P., et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15:2813-2824.
13. Sawcer S, Hellenthal G, Pirinen M., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476:214-219.
14. Dilthey A, Leslie S, Moutsianas L., et al. Multi-population classical HLA type imputation. PLoS Comput Biol 2013; 9:e1002877.
15. Price AL, Patterson NJ, Plenge R.M., Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904-909.
16. Ahn J, Yu K, Stolzenberg-solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19:2739-2745.
17. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45:1353-1360.
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
19. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
20. Glymour MM, Tchetgen EJT, Robins JM. Credible mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol 2012; 175:332-339.
21. Ascherio A, Munger KL, White R, et al Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71:306-314.
22. Munger KL, Levin LI, Hollis B.W., Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-2838.
23. Salzer J, Hallmans G, Nyström M, Stenlund H., Wadell G, Sundström P. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012; 79:2140-2145.
24. Disanto G, Sandve GK, Berlanga-Taylor AJ, et al. Vitamin d receptor binding, chromatin states and association with multiple sclerosis. Hum Mol Genet 2012; 21:3575-3586.
25. ∗1501 is regulated by vitamin D. PLoS Genet 2009; 5:e1000369.
26. Ramagopalan SV, Heger A, Berlanga A.J., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-1360.
27. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011; 11:584-596.
28. Aranow C. Vitamin D and the immune system. J Rheumatol 2010; 37:491-495.
29. Prietl B, Treiber G, Pieber T.R., Amrein K. Vitamin D and immune function. Nutrients 2013; 5:2502-2521.
30. Mokry LE, Ross S, Ahmad O.S., et al. Vitamin D and risk of multiple sclerosis: A Mendelian Randomization Study. PLoS Med 2015; 12:e1001866.
31. Tettey P, Simpson S, Taylor B.V., van der Mei IAF. Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci 2014; 347:23-33.
32. Berry DJ, Vimaleswaran KS, Whittaker J.C., Hingorani AD, Hyppönen E. Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLoS One 2012; 7:e37465.
33. Laursen JH, Sondergaard HB, Albrechtsen A, et al Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis. Mult Scler J 2014; 1414-1422.
34. Rito Y, Flores J, Fernández Aguilar Á, et al. Vitamin D in multiple sclerosis patients: not the same risk for everybody. Mult Scler 2016; 22:126-127.